Visura Expands Leadership Team with Key New Hire of Medical Director
LIGHT.
CAMERA.
IMAGE.
Esophageal Inlets Never Looked So Clear.
TEECAD
®
As the world's first, FDA-cleared disposable camera that seamlessly connects to a transesophageal echocardiogram (TEE) probe, TEECAD provides physicians with real-time visualization during intubation and promotes more efficient and effective probe placement.
With TEECAD, there is no need to navigate blind
TEECAD Delivers:
-
Precise and clear images of the esophagus
-
Seamless attachment to TEE probe
-
Atraumatic, soft silicone design; adding minimal diameter
View TEECAD footage in action and hear first-hand physician experience. Click "Watch TEECAD in Action" button for more.
Blind Intubation vs. TEECAD-Assisted Intubation
First Pass Intubation Success
No need to navigate blind - 91% first pass achieved with sighted intubation vs. 44% first pass achieved with blind intubation.
2
Reduce Complications
Drive with the lights on - clinical data demonstrates that sight-guided TEE intubations reduce oropharyngeal injuries by 50%
3
Reduce Cost-of-Care
No additional staff needs to be called in and use of real-time visualization to guide intubation reduces costly TEE complications
Recent News
Board of Directors
David Marmor, MD
Founder & CMO
Visura Technologies
Christine Horton
President & CEO
Visura Technologies
Kathy Tune
Board Chair & CFO/COO
Marani Health
Jim Reed
President
YKK Corporation of America
Stan Weissbrot
Angel Investor & Board Member
Allstate, Five Star Diamond Holdings
Visura Technologies, Inc.
8400 Normandale Lake Blvd
Suite 920
Bloomington, MN 55437
©2024 | Visura Technologies Inc. | All Rights Reserved | AP-GEN2-004 Rev C
TEECAD is a trademark of Visura Technolgies, Inc., registered in the U. S. and other countries.
2. Ozturk et al Use of McGrath MAC Video laryngoscope to AssistTransesophageal Echocardiography Probe Insertion in Intubated Patients. Journal of Cardiothoracic Anesthesia 2017 Feb
1. Mankad, S. Early results of the TEECAD System in 15 TEE paients at the Mayo Clinic Rochester.
The following U.S. and international patents apply to Visura Technologies products listed below, or use thereof.
This page is intended to serve as notice under 35 U.S.C. § 287(a).
US 10,265,046
US 10,045,758
US 10,376,237
Other Patents Pending. Updated 7/8/24.
US 10,925,576
JP 6668348
EU 3223713 B1